Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer

M. W. Audeh; R. T. Penson; M. Friedlander; B. Powell; K. M. Bell-McGuinn; C. Scott; J. N. Weitzel; J. Carmichael; A. Tutt

Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer

M. W. Audeh, R. T. Penson, M. Friedlander, B. Powell, K. M. Bell-McGuinn, C. Scott, J. N. Weitzel, J. Carmichael, A. Tutt

Research output: Contribution to journal › Meeting abstract

Original language	English
Journal	Journal of Clinical Oncology
Volume	27
Issue number	15
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e5bfd17be527417a9831196fcaa8919f,

title = "Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer",

author = "Audeh, {M. W.} and Penson, {R. T.} and M. Friedlander and B. Powell and Bell-McGuinn, {K. M.} and C. Scott and Weitzel, {J. N.} and J. Carmichael and A. Tutt",

year = "2009",

language = "English",

volume = "27",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "15",

}

TY - JOUR

T1 - Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer

AU - Audeh, M. W.

AU - Penson, R. T.

AU - Friedlander, M.

AU - Powell, B.

AU - Bell-McGuinn, K. M.

AU - Scott, C.

AU - Weitzel, J. N.

AU - Carmichael, J.

AU - Tutt, A.

PY - 2009

Y1 - 2009

M3 - Meeting abstract

SN - 1527-7755

VL - 27

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -